On Invalid Date, Tempest Therapeutics (NASDAQ: TPST) reported Q1 2023 earnings per share (EPS) of -$0.55, up 53.39% year over year. Total Tempest Therapeutics earnings for the quarter were -$7.64 million. In the same quarter last year, Tempest Therapeutics's earnings per share (EPS) was -$1.18.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.